Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Down to Business
  • Published:

CRISPR quality control on a chip

Combining the precision of CRISPR’s DNA searching ability with the speed and scalability of electronics, we have developed an ‘electronic DNA search engine’, called a CRISPR–Chip, which not only enables DNA detection without amplification, but also showcases the untapped potential of merging molecular biology with nanomaterial electronics. Here, we discuss highlights and challenges on the journey from the initial idea to the commercialization of the CRISPR–Chip.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CRISPR–Chip.

References

  1. Balderston, S. et al. Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor. Nat. Biomed. Eng. 5, 713–725 (2021).

    Article  CAS  PubMed  Google Scholar 

  2. Hajian, R. et al. Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor. Nat. Biomed. Eng. 3, 427–437 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ban, D. K. et al. A single multiomics transistor for electronic detection of SARS-Cov2 variants antigen and viral RNA without amplification. Adv. Mater. Technol. 8, 2201945 (2023).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge R. Bundy and M. Heltzen for contributions towards manuscript preparation. The CRISPR–Chip work was supported by discretionary funds to K.A. and National Science Foundation (NSF) award 2048283, National Institutes of Health (NIH) 1R01HL161361 and Cardea Service agreement to the Aran Lab.

Author information

Authors and Affiliations

Authors

Contributions

K.A. and B.R.G. prepared the manuscript.

Corresponding author

Correspondence to Kiana Aran.

Ethics declarations

Competing interests

K.A. is a co-founder of Cardea and CRISPR QC. B.R.G. is a co-founder of Cardea.

Additional information

Related links

Startup to commercialize the CRISPR–Chip: https://communities.springernature.com/posts/crispr-graphene-enabled-gene-detection

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aran, K., Goldsmith, B.R. CRISPR quality control on a chip. Nat Rev Bioeng 2, 194–195 (2024). https://doi.org/10.1038/s44222-024-00159-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44222-024-00159-4

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing